An Open-Label Rollover Extension Phase 2 Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of US-APR2020 In Subjects With CKD IV Completing The US-APR2020-01 Study
Purpose
Category
IRB Number
20220587HU
NCT Number
-
Open to Enrollment
Yes
Sponsor
-
Study Contact
Principal Investigator
Subrata Debnath
Subrata Debnath
(210) 508-2889
nath@uthscsa.edu
Eligibility
Eligible Ages
Eligible Genders
Accepts Healthy Volunteers
No
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups